Dr. Douglas Bree, M.D.
What this data tells you about Dr. Bree
Dr. Douglas Bree is a cardiovascular disease specialist in Houston, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Bree performed 2,927 Medicare services across 2,326 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bree received a total of $53,115 from 63 pharmaceutical and/or device companies across 744 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bree is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 446 | $87 | $314 |
| Regadenoson injection (Lexiscan) for heart stress test | 328 | $45 | $212 |
| Electrocardiogram (EKG), 12-lead | 312 | $11 | $126 |
| Echocardiogram, transthoracic | 277 | $140 | $1,461 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 253 | $25 | $35 |
| EKG interpretation and report | 244 | $6 | $50 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 132 | $49 | $406 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 131 | $341 | $3,509 |
| Office visit, established patient (20-29 min) | 129 | $59 | $212 |
| Hospital follow-up visit, moderate complexity | 99 | $63 | $211 |
| Initial hospital admission, moderate complexity | 97 | $104 | $401 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 82 | $21 | $120 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 59 | $10 | $63 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 59 | $19 | $102 |
| New patient office visit (45-59 min) | 43 | $113 | $483 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 34 | $43 | $175 |
| Evaluation of cardiac rhythm monitor system | 28 | $37 | $168 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $10 | $64 |
| Ultrasound of heart, follow-up | 22 | $20 | $119 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 21 | $67 | $296 |
| Remote pacemaker monitoring, 90 days | 20 | $23 | $149 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $2 | $252 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $80 | $516 |
| Hospital follow-up visit, high complexity | 18 | $96 | $302 |
| Cardiac catheterization | 17 | $212 | $1,310 |
| Initial hospital admission, high complexity | 13 | $140 | $588 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (43%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 10% for cardiovascular disease in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bree is a cardiac imaging specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 10% of TX peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bree experienced with office visit, established patient (30-39 min)?
Does Dr. Bree receive payments from pharmaceutical companies?
How do Dr. Bree's costs compare to other cardiologists in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology